News & Perspective

Jun 20, 2017

Jun 20, 2017

News Scan for Jun 20, 2017

New Syrian polio cases
Inhaled anthrax vaccine

Oct 14, 2011

Oct 14, 2011

NIH contracts target broad-spectrum therapies for bioterror threats

(CIDRAP News) – The National Institutes of Health (NIH) yesterday announced it has awarded contracts, which could total $150 million over 5 years, to four companies to develop broad-spectrum therapies that could help the nation respond to a bioterror attack or other public health emergency.

Feb 09, 2010

Feb 09, 2010

Major review of biodefense measures to start soon

(CIDRAP News) – A comprehensive review of the nation's tools for reducing the impact of a biological weapons attack or other public health emergency—prompted in part by last fall's delays in delivery of the pandemic H1N1 vaccine—is due to get under way in the next few weeks with a pair of conferences.

Sep 26, 2008

Sep 26, 2008

Emergent garners $29 million for new anthrax vaccine

(CIDRAP News) – Emergent BioSolutions announced today that it has received a $29.7 million contract from the federal government to continue work on another of its next-generation anthrax vaccine candidates.

Sep 09, 2008

Sep 09, 2008

HHS funds work on new anthrax antitoxin

(CIDRAP News) – Emergent BioSolutions Inc. recently announced that it won a federal contract worth $24.3 million to develop a monoclonal antibody treatment to block the effects of anthrax toxin.

Aug 26, 2008

Aug 26, 2008

Anthrax probe prompts concerns about military labs

(CIDRAP News) –US Navy and Air Force officials recently reported a suspension of work in their biodefense laboratories to allow a thorough review of safety procedures, following the Army's announcement in early August that it would review security measures at the lab that housed the work of the late Bruce E. Ivins, whom federal officials believe played a role in the 2001 anthrax attacks.

Oct 16, 2007

Oct 16, 2007

US funds work on drugs for plague, tularemia, anthrax

(CIDRAP News) – The US government recently awarded contracts totaling about $34 million to two companies for development of drugs to treat pneumonic plague, tularemia, and anthrax, three of the diseases terrorists are deemed most likely to try to exploit.

May 09, 2006

May 09, 2006

Vaccine may permit shorter antibiotic course for anthrax

(CIDRAP News) – Combining vaccination with 14 days of antibiotic therapy after exposure to airborne anthrax may be an alternative to the current recommendation of 60 days of antibiotics alone, according to an animal study reported in the Proceedings of the National Academy of Sciences.

Aug 11, 2005

Aug 11, 2005

New biosafety level 4 lab breaks ground at UTMB, Galveston

Aug 11, 2004 (CIDRAP News) – Government officials and scientists yesterday recognized the formal opening of construction on a laboratory that will house research on the most dangerous emerging infectious diseases and potential bioterrorism agents.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»